Key Features of AI in Healthcare and Biomedical Research
It is no secret that AI is reshaping the pharma industry: faster target ID and recruitment, smarter engagement, stronger RWE, and better patient experience. As regulations tighten and stakeholders demand transparency, equity, and proof of impact, knowing where AI creates both value and risk is now a strategic must for every pharma leader.
To help you cut through the noise, Reuters Events have produced a new whitepaper, ‘Key Features of AI in Healthcare and Biomedical Research’, which distills the most important AI trends, risks, and opportunities, and gives you practical takeaways you can use now.
Key topics of the whitepaper include:
- Ethics, AI and the Commercial Dimension
- The Ethics of Clinical Decision Support
- Ethics of AI-powered conversations in healthcare
- AI in Clinical Trials: Navigating the Transformation of Modern Medical Research
- AI and Ethics in Drug Discovery
- AI and Ethics in Electronic Health Records
- Electronic Health Records and Ethics in AI
- Why Patients Should Own Their Data in the Age of AI
Download your free whitepaper for exclusive insights from CSL Behring, Roche, Teva Pharmaceuticals, and more >>>
Key contributors featured in the whitepaper:
- Sander Ruitenberg, Global Head of Customer Engagement, CSL Behring
- Timothé Ménard, Global Head, Quality Excellence Digital, Roche
- Rachel Dunscombe, Founding CEO, NHS Digital Academy
- Dr Allison Gardner, MP, Chair, AllParty Parliamentary Group on AI
- Peter Grolimund, Founder, Data4all
- Alyssa Fenoglio, VP, Global Head of Digital Commercial, Teva Pharmaceuticals
I hope you enjoy the report!
Please let me know if you have any feedback, or if you want to get involved with the event.
Kind regards,
Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.